214 related articles for article (PubMed ID: 18347139)
1. A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.
Handeli S; Simon JA
Mol Cancer Ther; 2008 Mar; 7(3):521-9. PubMed ID: 18347139
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
[TBL] [Abstract][Full Text] [Related]
3. Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.
Zurlo D; Assante G; Moricca S; Colantuoni V; Lupo A
Biochim Biophys Acta; 2014 Jul; 1840(7):2361-72. PubMed ID: 24735796
[TBL] [Abstract][Full Text] [Related]
4. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin.
Liu J; Wang H; Zuo Y; Farmer SR
Mol Cell Biol; 2006 Aug; 26(15):5827-37. PubMed ID: 16847334
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.
Fujisawa T; Sugiyama M; Tomimoto A; Wada K; Endo H; Takahashi H; Yoneda K; Yoneda M; Inamori M; Saito S; Terauchi Y; Kadowaki T; Tsuchiya N; Nakagama H; Nakajima A
J Pharmacol Sci; 2008 Dec; 108(4):535-44. PubMed ID: 19075513
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdelta.
Han C; Lim K; Xu L; Li G; Wu T
J Cell Biochem; 2008 Oct; 105(2):534-45. PubMed ID: 18636547
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid activates β-catenin/T cell factor signaling, which contributes to the suppression of apoptosis in H19-7 cells.
Sun Y; Kim NH; Ji L; Kim SH; Lee J; Rhee HJ
Mol Med Rep; 2013 Dec; 8(6):1729-33. PubMed ID: 24145616
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
9. Activation of PPARγ2 by PPARγ1 through a functional PPRE in transdifferentiation of myoblasts to adipocytes induced by EPA.
Luo H; Zhou Y; Hu X; Peng X; Wei H; Peng J; Jiang S
Cell Cycle; 2015; 14(12):1830-41. PubMed ID: 25892270
[TBL] [Abstract][Full Text] [Related]
10. Streptonigrin inhibits β-Catenin/Tcf signaling and shows cytotoxicity in β-catenin-activated cells.
Park S; Chun S
Biochim Biophys Acta; 2011 Dec; 1810(12):1340-5. PubMed ID: 21763403
[TBL] [Abstract][Full Text] [Related]
11. The Peroxisome Proliferator-Activated Receptor (PPAR)-
Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
[TBL] [Abstract][Full Text] [Related]
12. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
[TBL] [Abstract][Full Text] [Related]
13. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
[TBL] [Abstract][Full Text] [Related]
14. Repression of beta-catenin signaling by PPAR gamma ligands.
Lu D; Carson DA
Eur J Pharmacol; 2010 Jun; 636(1-3):198-202. PubMed ID: 20303941
[TBL] [Abstract][Full Text] [Related]
15. N-Aryl benzenesulfonamide inhibitors of [3H]-thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.
Kril LM; Vilchez V; Jiang J; Turcios L; Chen C; Sviripa VM; Zhang W; Liu C; Spear B; Watt DS; Gedaly R
Bioorg Med Chem Lett; 2015 Sep; 25(18):3897-9. PubMed ID: 26243371
[TBL] [Abstract][Full Text] [Related]
16. The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells.
Jansson EA; Are A; Greicius G; Kuo IC; Kelly D; Arulampalam V; Pettersson S
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1460-5. PubMed ID: 15665104
[TBL] [Abstract][Full Text] [Related]
17. PPARδ signaling regulates colorectal cancer.
You M; Yuan S; Shi J; Hou Y
Curr Pharm Des; 2015; 21(21):2956-9. PubMed ID: 26004416
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.
Guo F; Ren X; Dong Y; Hu X; Xu D; Zhou H; Meng F; Tian W; Zhao Y
Gene; 2016 Jun; 584(1):31-37. PubMed ID: 26956036
[TBL] [Abstract][Full Text] [Related]
19. Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription.
Zeller J; Turbiak AJ; Powelson IA; Lee S; Sun D; Showalter HD; Fearon ER
Bioorg Med Chem Lett; 2013 Nov; 23(21):5814-20. PubMed ID: 24060489
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin Pathway-Mediated PPARδ Expression during Embryonic Development Differentiation and Disease.
Sidrat T; Rehman ZU; Joo MD; Lee KL; Kong IK
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
